What determines whether a drug will bind to a receptor among many binding sites in a cell?

What determines whether a drug will bind to a receptor among many binding sites in a cell?

• A. The molecular features such as size, shape, hydrophobicity, flexibility, and electrical charge
• B. The drug's color
• C. The time of day it's administered
• D. The patient's blood type

Answer: (A)

Binding depends on molecular recognition: the drug must be physically and chemically compatible with the receptor's binding site. The main determinants are the drug’s size and shape, its hydrophobic/hydrophilic character, its flexibility, and its electrical charge. These features determine whether the drug can fit into the binding pocket and form favorable noncovalent interactions with the receptor’s amino acids—such as hydrogen bonds, ionic interactions, van der Waals forces, and hydrophobic contacts. If this compatibility exists, the drug can bind tightly and modulate the receptor’s activity. External factors like color, time of day, or a patient’s blood type don’t influence this molecular fit, whereas affinity (how strong the interaction is) and concentration govern how likely binding is under physiological conditions. In short, structural and chemical complementarity between drug and binding site dictates binding among many sites.

Binding depends on molecular recognition: the drug must be physically and chemically compatible with the receptor's binding site. The main determinants are the drug’s size and shape, its hydrophobic/hydrophilic character, its flexibility, and its electrical charge. These features determine whether the drug can fit into the binding pocket and form favorable noncovalent interactions with the receptor’s amino acids—such as hydrogen bonds, ionic interactions, van der Waals forces, and hydrophobic contacts. If this compatibility exists, the drug can bind tightly and modulate the receptor’s activity. External factors like color, time of day, or a patient’s blood type don’t influence this molecular fit, whereas affinity (how strong the interaction is) and concentration govern how likely binding is under physiological conditions. In short, structural and chemical complementarity between drug and binding site dictates binding among many sites.